Alpha 2.0
Login Register
» Authors » Mark Phelan

Mark Phelan

Explore the profile of Mark Phelan including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 126
Followers 0
Related Specialties
General Medicine
Psychiatry
Rheumatology
Top 10 Co-Authors
Christopher G Davey
Sarah E Hetrick
Michael Berk
Aswin Ratheesh
Sue M Cotton
Andrew M Chanen
Olivia M Dean
Simon Rice
G Paul Amminger
Amelia L Quinn
Published In
Early Interv Psychiatry
Nat Clin Pract Rheumatol
Cochrane Database Syst Rev
SAGE Open Med
J Affect Disord
Affiliations
Soon will be listed here.
Recent Articles
1.
An Enhanced Social Networking Intervention for Young People with Active Suicidal Ideation: Safety, Feasibility and Acceptability Outcomes
Bailey E, Alvarez-Jimenez M, Robinson J, DAlfonso S, Nedeljkovic M, Davey C, et al.
Int J Environ Res Public Health . 2020 Apr; 17(7). PMID: 32260111
Online social networking interventions have potential to support young people who experience suicidal thoughts by specifically addressing interpersonal risk factors for suicide, but may also pose a risk of harm....
2.
Youth Depression Alleviation with Anti-inflammatory Agents (YoDA-A): a randomised clinical trial of rosuvastatin and aspirin
Berk M, Mohebbi M, Dean O, Cotton S, Chanen A, Dodd S, et al.
BMC Med . 2020 Jan; 18(1):16. PMID: 31948461
Background: Inflammation contributes to the pathophysiology of major depressive disorder (MDD), and anti-inflammatory strategies might therefore have therapeutic potential. This trial aimed to determine whether adjunctive aspirin or rosuvastatin, compared...
3.
Early intervention for bipolar disorder - Do current treatment guidelines provide recommendations for the early stages of the disorder?
Chia M, Cotton S, Filia K, Phelan M, Conus P, Jauhar S, et al.
J Affect Disord . 2019 Aug; 257:669-677. PMID: 31377603
Background: Interventions early in the course of bipolar disorder (BD) may have the potential to limit its functional and symptomatic impact. However, the implementation of specific early interventions for BD...
4.
The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial
Davey C, Chanen A, Hetrick S, Cotton S, Ratheesh A, Amminger G, et al.
Lancet Psychiatry . 2019 Aug; 6(9):735-744. PMID: 31371212
Background: Medication is commonly used to treat youth depression, but whether medication should be added to cognitive behavioural therapy (CBT) as first-line treatment is unclear. We aimed to examine whether...
5.
The Youth Mood Clinic: an innovative service for the treatment of severe and complex depression
Rice S, Halperin S, Cahill S, Cranston I, Phelan M, Hetrick S, et al.
Australas Psychiatry . 2017 Feb; 25(2):112-116. PMID: 28135816
Objective: Depression is the leading cause of disability for Australians from late adolescence through mid-adulthood, and effective treatments can positively impact subsequent life course trajectories. A treatment model for the...
6.
Integrating family work into the treatment of young people with severe and complex depression: a developmentally focused model
Rice S, Halperin S, Blaikie S, Monson K, Stefaniak R, Phelan M, et al.
Early Interv Psychiatry . 2016 Oct; 12(2):258-266. PMID: 27696760
Aim: Although models of family intervention are clearly articulated in the child and early adolescent literature, there is less clarity regarding family intervention approaches in later adolescence and emerging adulthood....
7.
Development of practice principles for the management of ongoing suicidal ideation in young people diagnosed with major depressive disorder
Rice S, Simmons M, Bailey A, Parker A, Hetrick S, Davey C, et al.
SAGE Open Med . 2016 Jan; 2:2050312114559574. PMID: 26770751
Objectives: There is a lack of clear guidance regarding the management of ongoing suicidality in young people experiencing major depressive disorder. This study utilised an expert consensus approach in identifying...
8.
Youth Depression Alleviation-Augmentation with an anti-inflammatory agent (YoDA-A): protocol and rationale for a placebo-controlled randomized trial of rosuvastatin and aspirin
Quinn A, Dean O, Davey C, Kerr M, Harrigan S, Cotton S, et al.
Early Interv Psychiatry . 2015 Nov; 12(1):45-54. PMID: 26542332
Aim: There is growing support for the role of inflammation and oxidative stress in the pathophysiology of major depressive disorder (MDD). This has led to the development of novel strategies...
9.
The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): study protocol for a randomised control trial
Davey C, Chanen A, Cotton S, Hetrick S, Kerr M, Berk M, et al.
Trials . 2014 Nov; 15:425. PMID: 25370185
Background: The aim of the Youth Depression Alleviation-Combined Treatment (YoDA-C) study is to determine whether antidepressant medication should be started as a first-line treatment for youth depression delivered concurrently with...
10.
Interventions for preventing relapse and recurrence of a depressive disorder in children and adolescents
Cox G, Fisher C, De Silva S, Phelan M, Akinwale O, Simmons M, et al.
Cochrane Database Syst Rev . 2012 Nov; 11:CD007504. PMID: 23152246
Background: Depressive disorders often begin during childhood or adolescence. There is a growing body of evidence supporting effective treatments during the acute phase of a depressive disorder. However, little is...